Anaphylaxis and hypersensitivity in trials of intravenous pertuzumab + trastuzumab (PH IV) or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) for HER2-positive breast cancer (BC) Meeting Abstract
| Authors: | Swain, S. M.; Tan, A.; Gianni, L.; Kümmel, S.; Dang, C.; Schneeweiss, A.; O'Shaughnessy, J.; Liu, H.; Aguila, C.; Heeson, S.; Macharia, H.; Restuccia, E.; Loibl, S. |
| Abstract Title: | Anaphylaxis and hypersensitivity in trials of intravenous pertuzumab + trastuzumab (PH IV) or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) for HER2-positive breast cancer (BC) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S419 |
| End Page: | S420 |
| Language: | English |
| ACCESSION: | WOS:000700527700139 |
| DOI: | 10.1016/j.annonc.2021.08.419 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 138P -- Source: Wos |
